Ionis Report PositiveData from Phase2 Study of AKCEA-APO(a)-LRx Long

Ionis Pharmaceuticals, Inc.NASDAQ

Description

⋅ Sep 24, 2018 5:07 PM

IONS: Ionis Pharmaceuticals, Inc.
2018-09-24 07:00:00
Akcea and Ionis Report Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx